Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

2 papers

Deep Brain Stimulation in Treatment-Resistant Depression: A Systematic Review and Meta-Analysis on Efficacy and Safety

Youliang Wu, Jiajie Mo, Lisen Sui, Jianguo Zhang, Wenhan Hu, Chao Zhang, et al.
Frontiers in Neuroscience Summary & key facts 2021 74 citations

This review combined 17 studies of deep brain stimulation (DBS) for people with treatment-resistant depression. Across studies, about 56% of patients showed a clinical response and 35% reached remission, while 14% later had recurrence. Adverse events were common (about 67%), and the two randomized trials did not show a clear,…

Neurological disorders and treatments Parkinson's Disease Mechanisms and Treatments Transcranial Magnetic Stimulation Studies

Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression

Weronika Dębowska, Magdalena Więdłocha, Marta Dębowska, Zuzanna Kownacka, Piotr Marcinowicz, Agata Szulc
Frontiers in Neuroscience Summary & key facts 2023 10 citations

This paper looks at studies that use transcranial magnetic stimulation and ketamine together to treat depression that has not improved with usual treatments. It notes that each method can reduce depressive symptoms on its own. Some recent research suggests that giving them together might make the benefits stronger and last…

Functional Brain Connectivity Studies Transcranial Magnetic Stimulation Studies Treatment of Major Depression Ketamine
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.